BarbaraAParkerMD

Oncology • La Jolla, CA

Breast Cancer

Professor of Medicine, UCSD, Emerita

Join to view full profile

Dr. Parker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Parker's full profile

Already have an account?

Office
3855 Health Sciences Dr
Mail Code 0987
La Jolla, CA 92093
Phone+1 858-249-3248

Fax+1 858-249-3250
Is this information wrong?

Summary

I am a breast medical oncologist and former senior cancer center administrator with over 30 years of experience in clinical care, clinical and translational research, cancer strategic planning and cancer clinical operations.

The Importance of the Patient Partnership

Interview with Dr. Parker regarding her perspective on breast medical oncology and the importance of partnering with patients.

Education & Training

University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1987
University of California (San Diego) Medical CenterChief Residency, Internal Medicine, 1984 - 1985
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1981 - 1984
Stanford University School of MedicineClass of 1981

Certifications & Licensure

CA State Medical License 1982 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Docs San Diego 2006-2020
Lifetime Achievement Award American Cancer Society San Diego, 2019
Lifetime Achievement Award UCSD Moores Cancer Center, 2018
Leonard Tow Humanism in Medicine Award Arnold P. Gold Foundation, UCSD School of Medicine, 2007
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Join now to see all

Clinical Trials

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B Schwab, Emily I Pittman, Minya Pu, Elizabeth Weihe, Emanuela M Ghia, Laura Z Rassenti, Alfredo Molino...> ;Breast Cancer Research. 2024 Mar 13
1 citations
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.
Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B Schwab, Emily I Pittman, Minya Pu, Elizabeth Weihe, Emanuela M Ghia, Laura Z Rassenti, Alfredo Molino...> ;Breast Cancer Research. 2024 Feb 26
2 citations
Growth signaling autonomy in circulating tumor cells aids metastatic seeding.
Sinha, S., Farfel, A., Luker, K., Luker, G., Ghosh, P., Parker, B., Yeung, K.> ;PNAS Nexus. 2024 Feb 1
4 citations
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
Barbara A Parker, Rebecca A Shatsky, Richard B Schwab, Anne M Wallace, , Denise M Wolf, Gillian L Hirst, Lamorna Brown-Swigart, Laura J Esserman, Laura J van 't Veer, ...> ;Breast Cancer Research and Treatment. 2023 Jun 1
4 citations
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastati...
Aditya Bardia, Ingrid Mayer, Eric Winer, Hannah M Linden, Cynthia X Ma, Barbara A Parker, Meritxell Bellet, Carlos L Arteaga, Sravanthi Cheeti, Mary Gates, Ching-Wei C...> ;Breast Cancer Research and Treatment. 2023 Jan 1
Why It Is Time to Challenge Entrenched Beliefs About Breast Cancer Screening.
Laura J Esserman, Barbara A Parker, Andrea Z LaCroix> ;Journal of Women's Health. 2022 Jul 1
9 citations
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer tri...
M Marczyk, A Mrukwa, C Yau, D Wolf, Y-Y Chen, R Balassanian, R Nanda, B A Parker, G Krings, H Sattar, J C Zeck, K S Albain, J C Boughey, M C Liu, A D Elias, A S Clark,...> ;Annals of Oncology. 2022 Aug 1
9 citations
Reductions in sleep quality and circadian activity rhythmicity predict longitudinal changes in objective and subjective cognitive functioning in women treated for brea...
Sonia Ancoli-Israel, Lianqi Liu, Loki Natarajan, Michelle Rissling, Ariel B Neikrug, Shawn D Youngstedt, Paul J Mills, Georgia R Sadler, Joel E Dimsdale, Barbara A Par...> ;Supportive Care in Cancer. 2022 Apr 1
37 citations
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...
W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein, Lajos Pusztai, Rita Nanda, Barbara A. Parker, Brian Datnow, Gregor Krings, Shi Wei, Mi...> ;JAMA Oncology. 2021 Sep 16
15 citations
The WISDOM study: a new approach to screening can and should be tested.
Laura J. Esserman, Martin Eklund, Laura J. van't Veer, Yiwey Shieh, Jeffrey A. Tice, Elad Ziv, Amie Blanco, Celia P. Kaplan, Robert A. Hiatt, Allison Stover Fiscalini,...> ;Breast Cancer Research and Treatment. 2021 Sep 16
1 citations
Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry.
Yash S Huilgol, Holly Keane, Yiwey Shieh, Robert A. Hiatt, Jeffrey A. Tice, Lisa Madlensky, Leah Sabacan, Allison Stover Fiscalini, Elad Ziv, Irene Acerbi, Mandy Che, ...> ;NPJ Breast Cancer. 2021 Aug 3
8 citations
KRAS-Mutated, Estrogen Receptor-Positive Low-Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery
Shumei Kato, Thomas McFall, Kenta Takahashi, Kasey Bamel, Sadakatsu Ikeda, Ramez N. Eskander, Steven C. Plaxe, Barbara A. Parker, Edward C. Stites, Razelle Kurzrock> ;The Oncologist. 2021 Apr 1
4 citations
A randomized trial of physical activity for cognitive functioning in breast cancer survivors: Rationale and study design of I can! improving cognition after cancer.
Sheri J. Hartman, Lauren S Weiner, Loki Natarajan, Dorothy D. Sears, Barton W. Palmer, Barbara A. Parker, Tim A. Ahles, Melinda L. Irwin, Kaylene Au> ;Contemporary Clinical Trials. 2021 Jan 24
2 citations
Cutaneous intralymphatic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma arising in a patient with multiple rounds of breast implants.
Huan-You Wang, John A. Thorson, Brian Hinds, William Swalchick, Barbara A. Parker, Alice Chong, Anne M. Wallace, Aaron M. Goodman> ;Journal of Cutaneous Pathology. 2021 May 1
17 citations
Continuous, objective measurement of physical activity during chemotherapy for breast cancer: the Activity in Treatment pilot study.
Sandahl H Nelson, Lauren S Weiner, Loki Natarajan, Barbara A. Parker, Ruth E. Patterson, Sheri J. Hartman> ;Translational Behavioral Medicine. 2020 Oct 8
28 citations
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors
, , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2020 Feb 7
42 citations
Research-based PAM50 signature and long-term breast cancer survival
Minya Pu, Karen Messer, Sherri R. Davies, Tammi L. Vickery, Emily Pittman, Barbara A. Parker, Matthew J. Ellis, Shirley W. Flatt, Catherine R. Marinac, Sandahl H Nelso...> ;Breast Cancer Research and Treatment. 2020 Jan 1
15 citations
Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis
Kamrul Hasan, George F. Widhopf, Suping Zhang, Sharon M. Lam, Zhouxin Shen, Steven P. Briggs, Barbara A. Parker, Thomas J. Kipps> ;NPJ Breast Cancer. 2019 Oct 25
20 citations
Mediators of a Physical Activity Intervention on Cognition in Breast Cancer Survivors: Evidence From a Randomized Controlled Trial.
Sheri J. Hartman, Lauren S Weiner, Sandahl H Nelson, Loki Natarajan, Ruth E. Patterson, Barton W. Palmer, Barbara A. Parker, Dorothy D. Sears> ;JMIR Cancer. 2019 Oct 11
5 citations
miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study.
Loki Natarajan, Minya Pu, Sherri R. Davies, Tammi L. Vickery, Sandahl H Nelson, Emily Pittman, Barbara A. Parker, Matthew J. Ellis, Shirley W. Flatt, Elaine R. Mardis,...> ;Cancer Epidemiology, Biomarkers & Prevention. 2019 Sep 1
11 citations
The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the Reach for Health study
Sheri J. Hartman, Sandahl H Nelson, Catherine R. Marinac, Loki Natarajan, Barbara A. Parker, Ruth E. Patterson> ;Psycho-Oncology. 2019 Aug 1
41 citations
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
Hyman B. Muss, Mei Yin C. Polley, Donald A. Berry, Heshan Liu, C. Cirrincione, Maria Theodoulou, Ann M. Mauer, Alice B. Kornblith, Ann H. Partridge, Lynn G. Dressler, ...> ;Journal of Clinical Oncology. 2019 Jul 24
8 citations
Contraceptive utilization and counseling among breast cancer survivors
Sheila K. Mody, Jessica R. Gorman, Lisa P. Oakley, Tracy M. Layton, Barbara A. Parker, Danielle M. Panelli> ;Journal of Cancer Survivorship. 2019 May 8
29 citations
Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies.
Rebecca Shatsky, Barbara A. Parker, Nam Bui, Teresa Helsten, Richard Schwab, Sarah Boles, Razelle Kurzrock> ;Molecular Cancer Therapeutics. 2019 May 1
5 citations
Examining Indigenous food sovereignty as a conceptual framework for health in two urban communities in Northern Ontario, Canada.
Lana Ray, Kristin Burnett, Anita Cameron, Serena Joseph, Joseph LeBlanc, Barbara A. Parker, Angela Recollet, Catherine Sergerie> ;Global Health Promotion. 2019 Apr 1
Join now to see all

Press Mentions

Researchers to Test Novel Drug Combination Against Toughest Breast CancersAugust 27th, 2018
UCSD Launches New Clinical Trial for Breast Cancer DrugAugust 27th, 2018